| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 05/16/2002 | US20020058785 Novel lipopeptides as antibacterial agents |
| 05/16/2002 | US20020058696 Chelate compound-containing antibacterial agent for helicobacter pylori |
| 05/16/2002 | US20020058687 For therapy and prohylaxis of inflammatory diseases including joint inflammation, Crohn's disease, and inflammatory bowel disease; respiratory diseases such as chronic obstructive pulmonary disease (COPD) including asthma, chronic bronchitis |
| 05/16/2002 | US20020058636 Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| 05/16/2002 | US20020058635 Purine L-nucleosides, analogs and uses thereof |
| 05/16/2002 | US20020058631 Dipeptide derivatives |
| 05/16/2002 | US20020058630 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 05/16/2002 | US20020058616 Coadministration of a an oral bioavailability-enhancing agent (e.g., a cyclosporin F or ketoconazole) with a drug that exhibits poor or inconsistent oral bioavailability (e.g., paclitaxel, docetaxel or etoposide) |
| 05/16/2002 | US20020058614 Especially administered by direct injection into the afflicted cartilagenous region or joint. |
| 05/16/2002 | US20020058611 Therapeutic agent is conjugated to the carrier via a biodegradable disulfide bond. |
| 05/16/2002 | US20020058607 Containing the amino acid sequence (G/S/A/E)-L-F-(F/I/L); each - is a peptide bond, each parenthesis encloses amino acids which are alternatives to one other, and each slash separating the alternative amino acids. |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058062 At least 13% glucoside isoflavones and 0.6-1.5 parts 3 soya saponins per 1 part by weight of glucoside isoflavones; treating pre or post menopausal symptoms, breast and prostate cancer, and alcoholism |
| 05/16/2002 | US20020058061 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 05/16/2002 | US20020058047 Vaccines |
| 05/16/2002 | US20020058046 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 05/16/2002 | US20020058044 LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. |
| 05/16/2002 | US20020058042 Non-IgA fc binding forms of the Group B streptococcal beta antigens |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058034 Treating or ameliorating an autoimmune condition, an allergic reaction or asthma |
| 05/16/2002 | US20020058013 Bacterial flora-controlling agent; periodontal-pocket bacterial flora-controlling agent that will eliminate or convert the bacteria, fungi, viruses and other microbes into a group of symbiotic bacteria. |
| 05/16/2002 | CA2429000A1 Adjuvant combination formulations |
| 05/16/2002 | CA2428808A1 Aryl phosphate derivatives of d4t |
| 05/16/2002 | CA2428318A1 Synergistic medicament containing aromatic agents and having an antagonistic, regenerative and/or protagonist decontamination effect |
| 05/16/2002 | CA2428164A1 Method for the treatment of inflammation |
| 05/16/2002 | CA2428055A1 Process for the preparation of latent antithrombin iii |
| 05/16/2002 | CA2427757A1 Therapeutic uses for ip3 receptor-mediated calcium channel modulators |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2425688A1 Extended release erythromycin derivatives |
| 05/16/2002 | CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/15/2002 | EP1205559A1 Method for detecting pathogenic microorganism and antimicrobial agent, method for evaluating the drug effect of antimicrobial agent, and antimicrobial agents |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205478A1 p38MAP KINASE INHIBITORS |
| 05/15/2002 | EP1205191A1 Targeted modification of intracellular compounds |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204753A2 Invasive bacteria based viral vaccines |
| 05/15/2002 | EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |
| 05/15/2002 | EP1204677A2 Cyclohexapeptide compounds, process for their production and their use as a pharmaceutical |
| 05/15/2002 | EP1204676A1 Streptogramin derivatives, preparation and compositions containing same |
| 05/15/2002 | EP1204675A1 Streptogramin derivatives, production thereof and compositions containing the same |
| 05/15/2002 | EP1204670A2 Antibiotic agents |
| 05/15/2002 | EP1204667A1 An improved amorphous form of cefpodoxime proxetil |
| 05/15/2002 | EP1204666A1 Hexahydropyrrolo[1,2-c]pyrimidines as antiviral, antifungal and/or antitumor agents |
| 05/15/2002 | EP1204665A2 Chemokine receptor antagonists and methods of use therefor |
| 05/15/2002 | EP1204649A1 Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 05/15/2002 | EP1204645A2 Melanocortin-4 receptor binding compounds and methods of use thereof |
| 05/15/2002 | EP1204641A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans |
| 05/15/2002 | EP1204430A2 Conjugates and methods for the production thereof, and their use for transporting molecules via biological membranes |
| 05/15/2002 | EP1204425A2 Methods of modulating an immune response using immunostimulatory sequences and compositions for use therein |
| 05/15/2002 | EP1204424A1 Recombinant rsv virus expression systems and vaccines |
| 05/15/2002 | EP1204422A2 Stress-proteins from extra-cellular pathogens as vaccines against infectious agents |
| 05/15/2002 | EP1204420A2 Trehalose producing prokaryotic cells as vaccines |
| 05/15/2002 | EP1204416A1 Carnitine analogues as topical, microbicidal spermicides |
| 05/15/2002 | EP1204411A1 Apicidin-derived cyclic tetrapeptides |
| 05/15/2002 | EP1204321A2 Super-active porcine growth hormone releasing hormone analog |
| 05/15/2002 | EP1161247A4 Method for the treatment of severe chronic bronchitis (bronchiectasis) with an aerosolized antibiotic |
| 05/15/2002 | EP1071745A4 Process for synthesizing cox-2 inhibitors |
| 05/15/2002 | EP1049694B1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines |
| 05/15/2002 | EP0885234B1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
| 05/15/2002 | EP0865278B1 Use of 1-hydroxy-2-pyridones for treating mucosa diseases which are difficult to treat |
| 05/15/2002 | EP0809504B1 Anti-viral triazacyclododecane |
| 05/15/2002 | CN1349541A L-ribo-LNA analogues |
| 05/15/2002 | CN1349540A Antifungal ethers |
| 05/15/2002 | CN1349527A Substituted benzolactam compounds |
| 05/15/2002 | CN1349523A Novel lipoic acid derivatives, their prepn., and pharmaceutical compositions containing them |
| 05/15/2002 | CN1349510A Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
| 05/15/2002 | CN1349509A Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 05/15/2002 | CN1349504A Piperidine derivatives useful as CCR5 antagonists |
| 05/15/2002 | CN1349496A Caspase inhibitors and the use thereof |
| 05/15/2002 | CN1349408A Pegylated interferon alfa-CCR5 antagonist combination HIV therapy |
| 05/15/2002 | CN1349407A Monthly doses of glycopeptide antibiotics for treatment of streptococcus pneumponiae infections |
| 05/15/2002 | CN1348991A Rotavirus causing adult's diarrhea and its culture process |
| 05/15/2002 | CN1348813A Separating prepn process of effective part and active component of influenze virus resisting medicine |
| 05/15/2002 | CN1348795A Chinese medicine mixture for treating infantile infection of upper respiratory tract and pulmonitis |
| 05/15/2002 | CN1348781A Pulmonotis treating Chinese medicine powder |
| 05/15/2002 | CN1348778A Chinese medicine prepn for treating AIDS, cancer, hepatitis, diabetes and angiopathy |
| 05/15/2002 | CN1348767A Tinea pedis treating medicine |
| 05/15/2002 | CN1348763A Medicine composite for preventing or treaitng diseases relating to IL-12 over growth |
| 05/15/2002 | CN1084750C Process for producing cefazolin |
| 05/15/2002 | CN1084745C Method for preparing 1,3-oxythiapentane and its derivatives |
| 05/15/2002 | CN1084735C Substituted pyridine-2-ones and substituted pyridine-2-thiones as biocides |
| 05/15/2002 | CN1084628C Bezoar mux vomica powder medicine for treating rabies |
| 05/15/2002 | CN1084622C 药物 Drug |
| 05/15/2002 | CN1084621C 4,4-disubstituted (cyclohexan-1-ols-monomers and related compounds |
| 05/14/2002 | US6388132 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/14/2002 | US6388108 Microbiocides |
| 05/14/2002 | US6388092 Antitumor agent |
| 05/14/2002 | US6388056 Inhibition of transglutaminase-mediated microbial interaction with a mammalian host |
| 05/14/2002 | US6387947 Mixture containing ferulic acid; topical applying |
| 05/14/2002 | US6387943 Vancoresmycin, a process for its production and its use as a pharmaceutical |
| 05/14/2002 | US6387930 Antiarthritic agents; antiallergens; skin disorders; inflammatory bowel disorders |
| 05/14/2002 | US6387929 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 05/14/2002 | US6387916 Administering to humans, animals |
| 05/14/2002 | US6387906 Dermatophytes |
| 05/14/2002 | US6387898 Treatment for CNS injuries |
| 05/14/2002 | US6387896 Bicyclic oxazolidinones as antibacterial agents |
| 05/14/2002 | US6387892 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 05/14/2002 | US6387886 Method for the treatment of severe chronic bronchitis (bronchietasis) with an aerosolized antibiotic |